Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices

A Chieffo, D Dudek, C Hassager… - … Heart Journal Acute …, 2021 - academic.oup.com
There has been a significant increase in the use of short-term percutaneous ventricular
assist devices (pVADs) as acute circulatory support in cardiogenic shock and to provide …

Lactate clearance is associated with improved survival in cardiogenic shock: a systematic review and meta-analysis of prognostic factor studies

JA Marbach, S Stone, B Schwartz, M Pahuja… - Journal of cardiac …, 2021 - Elsevier
Objective Elevated blood lactate levels are strongly associated with mortality in patients with
cardiogenic shock. Recent evidence suggests that the degree and rate at which blood …

Pulmonary artery catheter use and risk of in-hospital death in heart failure cardiogenic shock

MK Kanwar, V Blumer, Y Zhang, SS Sinha… - Journal of cardiac …, 2023 - Elsevier
Abstract Background Pulmonary artery catheters (PACs) are increasingly used to guide
management decisions in cardiogenic shock (CS). The goal of this study was to determine if …

Clinical course of patients in cardiogenic shock stratified by phenotype

E Zweck, M Kanwar, S Li, SS Sinha, AR Garan… - Heart Failure, 2023 - jacc.org
Background Cardiogenic shock (CS) patients remain at 30% to 60% in-hospital mortality
despite therapeutic innovations. Heterogeneity of CS has complicated clinical trial design …

[HTML][HTML] Nrf2 activation: a key mechanism in stem cell exosomes-mediated therapies

Z Vahidinia, A Azami Tameh, S Barati… - Cellular & Molecular …, 2024 - Springer
Exosomes are nano-sized membrane extracellular vesicles which can be released from
various types of cells. Exosomes originating from inflammatory or injured cells can have …

[HTML][HTML] Integrated bioinformatics-based analysis of hub genes and the mechanism of immune infiltration associated with acute myocardial infarction

Y Wu, T Jiang, J Hua, Z Xiong, H Chen, L Li… - Frontiers in …, 2022 - frontiersin.org
Background Acute myocardial infarction (AMI) is a fatal disease that causes high morbidity
and mortality. It has been reported that AMI is associated with immune cell infiltration. Now …

Lactate clearance as a surrogate for mortality in cardiogenic shock: insights from the DOREMI trial

JA Marbach, P Di Santo, NK Kapur… - Journal of the …, 2022 - Am Heart Assoc
Background Recent studies have shown improved outcomes in cardiogenic shock through
protocols directed toward early identification and initiation of mechanical circulatory support …

[Retracted] Activation of PTEN/P13K/AKT Signaling Pathway by miRNA‐124‐3p‐Loaded Nanoparticles to Regulate Oxidative Stress Attenuates Cardiomyocyte …

Y Cheng, Q He, N Li, M Luo - Oxidative Medicine and Cellular …, 2022 - Wiley Online Library
As a common cardiovascular disease, acute myocardial infarction seriously affects the
health and life of patients. miRNAs play an important role in acute myocardial infarction …

[HTML][HTML] Cardiac troponin I but not N-terminal pro-B-type natriuretic peptide predicts outcomes in cardiogenic shock

T Schupp, J Rusnak, J Forner, K Weidner… - Journal of Personalized …, 2023 - mdpi.com
This study investigates the prognostic value of cardiac troponin I (cTNI) and N-terminal pro-B-
type natriuretic peptide (NT-proBNP) levels in patients with cardiogenic shock (CS). Data …

[HTML][HTML] Comprehensive bioinformatics analytics and in vivo validation reveal SLC31A1 as an emerging diagnostic biomarker for acute myocardial infarction

S Zhou, L Wang, X Huang, T Wang, Y Tang… - Aging (Albany …, 2024 - ncbi.nlm.nih.gov
Background: Globally, Acute Myocardial Infarction (AMI) is a common cause of heart failure
(HF), which has been a leading cause of mortality resulting from non-communicable …